Margaret Marshall
No más puestos en curso
Historial de carrera de Margaret Marshall
Antiguos cargos conocidos de Margaret Marshall.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Director Técnico/Científico/I+D | 01/01/2020 | 20/07/2023 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | 01/10/2014 | 01/02/2018 |
| KITE PHARMA INC | Director Técnico/Científico/I+D | 01/11/2012 | 01/09/2014 |
| PFIZER, INC. | Director Técnico/Científico/I+D | 01/12/2004 | 01/10/2012 |
Formación de Margaret Marshall.
| University of California San Diego | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Margaret Marshall
- Experiencia
